COMP <GO>
VERU vs ATHE // RSI-14 & 200D SMA MOMENTUM
Veru Inc. (NASDAQ) VS. Alterity Therapeutics Limited (NASDAQ) • 15-METRIC TALLY: VERU 1
— ATHE 1
▲ RSI-14 & 200D SMA MOMENTUM LEADER: VERU
LAST: $2.16 (-1.37%) • MKT CAP: $36.8M
rsi-technicals
39.4
LAST: $2.09 (-3.24%) • MKT CAP: $38.1M
rsi-technicals
26.4
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (VERU VS. ATHE)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | VERU | ATHE | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | — | — | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | — | — | — | TIE | /operating-margins <GO> |
| Net Profit Margin | — | — | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | — | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 2/9 | — | — | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum ACTIVE | 39.4 | 26.4 | +13.00 | VERU | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $36.8M | $38.1M | -$1.2M | ATHE | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | VERU REV | ATHE REV | VERU GROSS % | ATHE GROSS % | VERU FCF | ATHE FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $69.3M | — | — | — | -$30.0M | — |
| FY 2024 | $16.9M | — | 34.7% | — | -$21.8M | — |
| FY 2023 | $16.3M | — | — | — | -$88.0M | — |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
VERU // BETA —
ATHE // BETA —